Recombinant protein meningococcal serogroup B vaccine combined with outer membrane vesicles, Expert Opin. Biol. Ther, vol.11, pp.969-985, 2001. ,
Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus, Vaccine, vol.27, pp.2794-2803, 2009. ,
Multilocus sequence typing for global surveillance of meningococcal disease, FEMS Microbiol. Rev, vol.31, pp.15-26, 2007. ,
Neisseria meningitidis is structured in clades associated with restriction modification systems that modulate homologous recombination, Proc. Natl. Acad. Sci. U. S. A, vol.108, pp.4494-4499, 2011. ,
From tailor-made to ready-to-wear meningococcal B vaccines: longitudinal study of a clonal meningococcal B outbreak, Lancet Infect. Dis, vol.11, pp.455-463, 2011. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02083160
Surveillance of invasive bacterial diseases in Europe, Centers for Disease Control and Prevention, 2008. ,
Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of proteinbased vaccines, Proc. Natl. Acad. Sci. U. S. A, vol.107, pp.19490-19495, 2010. ,
Recombination within natural populations of pathogenic bacteria: short-term empirical estimates and long-term phylogenetic consequences, Proc. Natl. Acad. Sci. U. S. A, vol.98, pp.182-187, 2001. ,
Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine in toddlers and school children, Vaccine, vol.23, pp.2623-2627, 2005. ,
An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues, J. Immunol, vol.138, pp.4402-4407, 1987. ,
A universal vaccine for serogroup B meningococcus, Proc. Natl. Acad. Sci. U. S. A, vol.103, pp.10834-10839, 2006. ,
Establishment of a new human pneumococcal standard reference serum, 007sp. Clin. Vaccine Immunol, vol.18, pp.1728-1736, 2011. ,
Global epidemiology of meningococcal disease, Vaccine, vol.27, issue.2, pp.51-63, 2009. ,
Set-up and evaluation of interlaboratory studies, J. Chromatogr. A, vol.1158, pp.158-167, 2007. ,
Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis, Vaccine, vol.27, issue.2, pp.3-12, 2009. ,
Molecular typing of meningococci: recommendations for target choice and nomenclature, FEMS Microbiol. Rev, vol.31, pp.89-96, 2007. ,
Comparative study of different sources of pertussis toxin (PT) as coating antigens in IgG anti-PT enzyme-linked immunosorbent assays, Clin. Vaccine Immunol, vol.19, pp.64-72, 2012. ,
A concordance correlation coefficient to evaluate reproducibility, Biometrics, vol.45, pp.255-268, 1989. ,
Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms, Proc. Natl. Acad. Sci. U. S. A, vol.95, pp.3140-3145, 1998. ,
The VR2 epitope on the PorA P1.7-2,4 protein is the major target for the immune response elicited by the strain-specific group B meningococcal vaccine MeNZB, Clin. Vaccine Immunol, vol.13, pp.486-491, 2006. ,
Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine, Vaccine, vol.18, pp.2476-2481, 2000. ,
Multilaboratory comparison of Streptococcus pneumoniae opsonophagocytic killing assays and their level of agreement for the determination of functional antibody activity in human reference sera, Clin. Vaccine Immunol, vol.18, pp.135-142, 2011. ,
Serogroup B meningococcal vaccines: an unfinished story, Lancet Infect. Dis, vol.10, pp.112-124, 2010. ,
The challenge of post-implementation surveillance for novel meningococcal vaccines, Vaccine, vol.30, issue.2, pp.67-72, 2012. ,
A combination recombinant protein and outer membrane vesicle vaccine against serogroup B meningococcal disease, Expert Rev. Vaccines, vol.10, pp.575-588, 2011. ,
Advances in the development of vaccines against Neisseria meningitidis, N. Engl. J. Med, vol.362, pp.1511-1520, 2010. ,
Immunogenicity of 2 serogroup B outermembrane protein meningococcal vaccines: a randomized controlled trial in Chile, JAMA, vol.281, pp.1520-1527, 1999. ,